Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $1.2 billion.

  • Surgery Partners' Enterprise Value rose 46342.03% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 46342.03%. This contributed to the annual value of $1.1 billion for FY2024, which is 3356.82% up from last year.
  • As of Q3 2025, Surgery Partners' Enterprise Value stood at $1.2 billion, which was up 46342.03% from $1.2 billion recorded in Q2 2025.
  • Surgery Partners' Enterprise Value's 5-year high stood at $1.2 billion during Q3 2025, with a 5-year trough of -$152.0 million in Q2 2021.
  • In the last 5 years, Surgery Partners' Enterprise Value had a median value of $150.7 million in 2023 and averaged $357.2 million.
  • As far as peak fluctuations go, Surgery Partners' Enterprise Value plummeted by 43783.78% in 2021, and later surged by 134060.91% in 2023.
  • Surgery Partners' Enterprise Value (Quarter) stood at -$59.7 million in 2021, then skyrocketed by 198.99% to $59.1 million in 2022, then skyrocketed by 1340.61% to $851.4 million in 2023, then skyrocketed by 33.57% to $1.1 billion in 2024, then grew by 6.32% to $1.2 billion in 2025.
  • Its Enterprise Value stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.